# Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients

> **NCT04117477** · PHASE2 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 46 (actual)

## Conditions studied

- Allogeneic Hematopoietic Cell Transplantation

## Interventions

- **DRUG:** Xylitol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04117477
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-27
- **Primary completion:** 2021-03-20
- **Final completion:** 2021-03-20
- **Target enrollment:** 46 (ACTUAL)
- **Why stopped:** A new multisite study was opened in place of this study.
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04117477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04117477, "Xylitol - Healthcare Associated Infection Reduction in Stem Cell Transplant Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04117477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*